Wednesday, September 07, 2011

Par Pharmaceutical Engaged in Illegal Drug-Switching Scheme, U.S. Says - Bloomberg

Par Pharmaceutical Cos., a maker and distributor of generic drugs, engaged in an illegal drug- switching scheme to increase sales, the U.S. said in a lawsuit in which two Mylan Inc. units are also accused by a whistleblower of wrongdoing.

The U.S. joined a lawsuit against Par filed in 2006 by a whistleblower who previously settled similar claims against drugstore chains CVS Caremark Corp. and Walgreen’s. The U.S. complaint, filed in March 2009, was unsealed today in Chicago federal court. The suit has been joined by 20 states and the District of Columbia.

Posted via email from Jack's posterous

1 comment:

Michael Behn said...

Thanks for your attention to this case. For the complaint, exhibits and court documents, please visit www.PharmacyFraud.com